A substantial part of the NIH portfolio, appropriately, focuses on basic science. Basic science meaning fundamental biological facts that can be used in many many drug studies, other research where you don’t necessarily know specifically in advance when you’re doing it what the application’s going to be. The NIH, very appropriately, funds that work, especially work that’s not patentable, because no drug company has an incentive to do that work, and yet it’s vital.
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
